A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

NCT00124111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pegfilgrastim
DRUG: cyclophosphamide
DRUG: methotrexate
DRUG: 5-fluorouracil

Sponsor

Amgen